This inventor holds 1 USPTO granted patent. Top assignee: Amgen Inc.. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Hiroyuki Nawa: Innovator in Epilepsy Treatment
Introduction
Hiroyuki Nawa is a prominent inventor based in Niigata, France. He has made significant contributions to the field of medical science, particularly in the treatment of epilepsy. His innovative approach utilizes brain-derived neurotrophic factor (BDNF) for therapeutic purposes.
Latest Patents
Hiroyuki Nawa holds a patent for a method of treating epilepsy. This patent describes a novel approach that leverages the therapeutic use of BDNF to address this challenging neurological condition. He has 1 patent to his name, showcasing his commitment to advancing medical treatments.
Career Highlights
Nawa is currently associated with Amgen Inc., a leading biotechnology company. His work at Amgen has allowed him to collaborate with other experts in the field and contribute to groundbreaking research in epilepsy treatment.
Collaborations
Some of his notable coworkers include Josette Francedillaoise Carnahan and Antoine Depaulis. Their collective expertise enhances the innovative environment at Amgen, fostering advancements in medical science.
Conclusion
Hiroyuki Nawa's contributions to epilepsy treatment through his innovative patent highlight his role as a key figure in medical research. His work continues to inspire advancements in therapeutic methods for neurological disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile